Zacks Small Cap Research – BSEM: Medicare Issues Shouldn’t Impact BioStem – Go Health Pro
By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT We don’t often write about short-term movements in stocks we cover but the move in BioStem Technologies, Inc. (OTC:BSEM) has coincided with what seems to have been perceived as a fundamental change in the company and we want to make sure investors know the … Read more
